| Literature DB >> 33674575 |
Mehdi Eshraghi1, Pabalu P Karunadharma2, Juliana Blin3, Neelam Shahani1, Emiliano P Ricci3, Audrey Michel4, Nicolai T Urban5, Nicole Galli1, Manish Sharma1, Uri Nimrod Ramírez-Jarquín1, Katie Florescu1, Jennifer Hernandez1, Srinivasa Subramaniam6.
Abstract
The polyglutamine expansion of huntingtin (mHTT) causes Huntington disease (HD) and neurodegeneration, but the mechanisms remain unclear. Here, we found that mHtt promotes ribosome stalling and suppresses protein synthesis in mouse HD striatal neuronal cells. Depletion of mHtt enhances protein synthesis and increases the speed of ribosomal translocation, while mHtt directly inhibits protein synthesis in vitro. Fmrp, a known regulator of ribosome stalling, is upregulated in HD, but its depletion has no discernible effect on protein synthesis or ribosome stalling in HD cells. We found interactions of ribosomal proteins and translating ribosomes with mHtt. High-resolution global ribosome footprint profiling (Ribo-Seq) and mRNA-Seq indicates a widespread shift in ribosome occupancy toward the 5' and 3' end and unique single-codon pauses on selected mRNA targets in HD cells, compared to controls. Thus, mHtt impedes ribosomal translocation during translation elongation, a mechanistic defect that can be exploited for HD therapeutics.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33674575 PMCID: PMC7935949 DOI: 10.1038/s41467-021-21637-y
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919